mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
0.004 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.006 |